Nordea Investment Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.6M | Buy |
22,047
+4,260
| +24% | +$2.39M | 0.01% | 432 |
|
|
2026
Q1 | $9.84M | Buy |
17,787
+1,190
| +7% | +$763K | 0.01% | 449 |
|
|
2025
Q4 | $11.3M | Buy |
16,597
+8,845
| +114% | +$6.02M | 0.01% | 422 |
|
|
2025
Q3 | $4.9M | Sell |
7,752
-305
| -4% | -$185K | ﹤0.01% | 597 |
|
|
2025
Q2 | $4.3M | Buy |
8,057
+361
| +5% | +$173K | ﹤0.01% | 586 |
|
|
2025
Q1 | $3.19M | Buy |
7,696
+1,287
| +20% | +$559K | ﹤0.01% | 620 |
|
|
2024
Q4 | $2.66M | Buy |
6,409
+334
| +5% | +$147K | ﹤0.01% | 638 |
|
|
2024
Q3 | $3.06M | Sell |
6,075
-7,881
| -56% | -$3.83M | ﹤0.01% | 617 |
|
|
2024
Q2 | $6.86M | Buy |
13,956
+237
| +2% | +$119K | 0.01% | 470 |
|
|
2024
Q1 | $7.45M | Buy |
13,719
+1,839
| +15% | +$1M | 0.01% | 476 |
|
|
2023
Q4 | $6.6M | Buy |
11,880
+9
| +0.1% | +$4.22K | 0.01% | 482 |
|
|
2023
Q3 | $5.22M | Sell |
11,871
-448
| -4% | -$223K | 0.01% | 494 |
|
|
2023
Q2 | $6.19M | Sell |
12,319
-247
| -2% | -$118K | 0.01% | 471 |
|
|
2023
Q1 | $6.25M | Buy |
12,566
+283
| +2% | +$135K | 0.01% | 477 |
|
|
2022
Q4 | $4.96M | Sell |
12,283
-11,208
| -48% | -$4.35M | 0.01% | 522 |
|
|
2022
Q3 | $7.87M | Sell |
23,491
-8,880
| -27% | -$3.26M | 0.01% | 414 |
|
|
2022
Q2 | $11.3M | Sell |
32,371
-8,722
| -21% | -$3.56M | 0.02% | 359 |
|
|
2022
Q1 | $22.7M | Sell |
41,093
-2,316
| -5% | -$1.22M | 0.03% | 308 |
|
|
2021
Q4 | $28.8M | Sell |
43,409
-1,106
| -2% | -$694K | 0.03% | 294 |
|
|
2021
Q3 | $28.3M | Sell |
44,515
-1,468
| -3% | -$986K | 0.04% | 303 |
|
|
2021
Q2 | $29M | Sell |
45,983
-7,069
| -13% | -$3.9M | 0.04% | 297 |
|
|
2021
Q1 | $26M | Buy |
53,052
+1,539
| +3% | +$771K | 0.04% | 297 |
|
|
2020
Q4 | $25.8M | Buy |
51,513
+5,630
| +12% | +$2.52M | 0.04% | 281 |
|
|
2020
Q3 | $17.7M | Buy |
45,883
+36,911
| +411% | +$13.6M | 0.03% | 284 |
|
|
2020
Q2 | $2.92M | Buy |
8,972
+4,782
| +114% | +$1.38M | ﹤0.01% | 672 |
|
|
2020
Q1 | $1.01M | Buy |
4,190
+144
| +4% | +$37.6K | ﹤0.01% | 716 |
|
|
2019
Q4 | $1.06M | Hold |
4,046
| – | – | ﹤0.01% | 744 |
|
|
2019
Q3 | $1.11M | Sell |
4,046
-173
| -4% | -$48.1K | ﹤0.01% | 746 |
|
|
2019
Q2 | $1.16M | Sell |
4,219
-266
| -6% | -$65.5K | ﹤0.01% | 746 |
|
|
2019
Q1 | $1M | Buy |
4,485
+40
| +0.9% | +$8.26K | ﹤0.01% | 980 |
|
|
2018
Q4 | $827K | Hold |
4,445
| – | – | ﹤0.01% | 987 |
|
|
2018
Q3 | $1.11M | Hold |
4,445
| – | – | ﹤0.01% | 988 |
|
|
2018
Q2 | $969K | Hold |
4,445
| – | – | ﹤0.01% | 845 |
|
|
2018
Q1 | $851K | Sell |
4,445
-156
| -3% | -$28.8K | ﹤0.01% | 881 |
|
|
2017
Q4 | $720K | Hold |
4,601
| – | – | ﹤0.01% | 842 |
|
|
2017
Q3 | $715K | Buy |
4,601
+124
| +3% | +$19.6K | ﹤0.01% | 819 |
|
|
2017
Q2 | $723K | Hold |
4,477
| – | – | ﹤0.01% | 812 |
|
|
2017
Q1 | $692K | Buy |
4,477
+2,585
| +137% | +$356K | ﹤0.01% | 810 |
|
|
2016
Q4 | $222K | Hold |
1,892
| – | – | ﹤0.01% | 929 |
|
|
2016
Q3 | $213K | Hold |
1,892
| – | – | ﹤0.01% | 918 |
|
|
2016
Q2 | $176K | Buy |
+1,892
| New | +$162K | ﹤0.01% | 898 |
|
Other funds holding IDXX
MBI
CGI
WJWM
Nordea Investment Management's IDXX Position: Q2 2026 in Review
Nordea Investment Management increased its Idexx Laboratories (IDXX) stake by 24% in Q2 2026, buying an estimated $2.39M and bringing the position to 22,047 shares worth $11.6M. The position accounts for 0.01% of the portfolio, ranked #432.
Nordea Investment Management first reported a position in IDXX in Q2 2016 and has held it in 41 quarters since. The position peaked at $29M in Q2 2021. 659 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Nordea Investment Management held 22,047 shares of Idexx Laboratories worth $11.6M as of Q2 2026.
- Nordea Investment Management bought 4,260 Idexx Laboratories shares in Q2 2026, an estimated $2.39M.
- Idexx Laboratories made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #432 holding.
- Nordea Investment Management first reported a position in Idexx Laboratories in Q2 2016 and has held it in 41 quarters since.
- Nordea Investment Management's Idexx Laboratories position peaked at $29M in Q2 2021.
- 659 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.